Updates:Liberia releases last Ebola Patient after 1 week of no new case, Final testing of vaccine to begin

     

The World Health Organization (WHO) in a statement say that Liberia has released its last Ebola patient after going a week without any new cases of the virus. Beatrice Yardolo, 58, left a Chinese-run treatment centre in the capital Monrovia after two weeks of treatment.
Ms Yardolo, an English teacher, said she was "one of the happiest persons on earth" as she headed home from the treatment centre in Monrovia's Paynesville district.
She was the last patient undergoing treatment for the disease in Liberia.

 WHO officials say there were 132 new cases in Guinea and Sierra Leone in the week to 1 March.
It is the first time since May 2014 that Liberia has had no new cases of the virus, the officials added.
 But WHO officials have warned that populations are so mobile in the region that there could easily be fresh outbreaks in Liberia.
"We look at the three countries as really a single country, so while it's good news that Liberia itself has no new cases, the populations are so mobile in that region that there could easily be re-importations of cases," said WHO spokesman Gregory Hartl.
"We have to get down to zero in all three countries before we can consider this thing beaten."

The country has to have no new cases for 42 days to be declared Ebola-free.
In their latest assessment of the epidemic, WHO officials also warned that disease surveillance "may not be optimal" in Liberia because of the low number of samples.
They say that some communities are still resisting pleas to bring infected family members to treatment centres.
Only half of the 51 new infections in Guinea came from registered contacts of Ebola patients, the WHO says, and some cases are only identified after post-mortems are conducted.

Meanwhile, the final stage of testing of an experimental Ebola vaccine will begin in Guinea on 7 March, according to the WHO.
WHO Director-General Margaret Chan said that if a vaccine is found to be effective, "it will be the first preventive tool against Ebola in history".
the vaccinations will take place in areas of the Basse Guinee region of Guinea, an area which has the highest number of cases in the country.
The objectives of the trial are to assess whether a buffer zone can be established to stop further Ebola infections and to gauge its effectiveness among frontline Ebola workers.
source